8-K: Omada Health Reports Strong Q2 2026 Results, Announces CEO Transition

Omada Health announced robust Q2 2026 financial results, including 43% year-over-year revenue growth and a shift to net income, alongside a planned CEO transition.

Summary

• Omada Health reported strong financial results for the second quarter ended June 30, 2026.
• Revenue increased by 43% year-over-year to $88 million.
• Gross margin reached a record 73% (GAAP) and 74% (non-GAAP).
• The company achieved a net income of $5 million, a significant improvement from a net loss of $5 million in Q2 2025.
• Adjusted EBITDA was $11 million, up from a loss of $0.2 million in the prior year's quarter.
• Total members grew by 45% year-over-year.
• The company raised its full-year 2026 outlook for revenue and Adjusted EBITDA.
• Sean Duffy will transition from CEO to Executive Chairman, and Wei-Li Shao will become CEO on January 1, 2027.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, improved margins, and a transition to profitability, alongside a well-planned leadership succession.

Positives

• Revenue grew 43% year-over-year to $88 million in Q2 2026.
• Gross margin improved to a record 73% (GAAP) and 74% (non-GAAP) in Q2 2026.
• Achieved net income of $5 million in Q2 2026, a turnaround from a $5 million net loss in Q2 2025.
• Adjusted EBITDA of $11 million in Q2 2026, a substantial increase from a $0.2 million loss in Q2 2025.
• Total members increased by 45% year-over-year, indicating strong demand.
• Raised full-year 2026 revenue guidance to $334-$340 million (30% growth) and Adjusted EBITDA to $21-$27 million (fourfold increase).
• Successfully broadened partnership with Health Care Services Corporation (HCSC).
• Launched a new cholesterol management offering.

Negatives

• Despite improvements, the company has a history of net losses, with an accumulated deficit of $454.4 million as of June 30, 2026.
• Free Cash Flow for the six months ended June 30, 2026, was negative at $(11.0) million.

Risks

• The company has a limited operating history and faces challenges in managing growth effectively.
• Reliance on a limited number of customers and channel partners for a substantial portion of sales.
• Potential for changes in the healthcare industry and increased competition.
• Dependence on third-party suppliers.
• Cybersecurity threats and data privacy concerns.
• Compliance with evolving healthcare regulations and privacy laws.
• The company's ability to achieve and maintain market acceptance for its programs.
• Potential impact of negative media coverage.

Future Outlook

Omada Health raised its full-year 2026 outlook, now expecting revenue between $334 million and $340 million (approximately 30% year-over-year growth) and Adjusted EBITDA between $21 million and $27 million (a fourfold increase compared to 2025).

Management Comments

• "Our outstanding second quarter reflects the strength of our strategy, the momentum we've built across the business, and the exceptional team driving Omada forward," said Sean Duffy, co-founder and CEO of Omada Health.
• "Reflecting continued demand for our integrated between-visit care platform, total members increased 45% year over year as we expanded our commercial channels, deepened relationships with our leading PBM channels, and introduced our cholesterol management program with one of the nations largest retailers. The opportunity ahead is significant, and we'll remain focused on disciplined execution as we look to broaden our capabilities, deepen customer relationships and improve the health of even more members."
• "Over the past seven years, Wei-Li and I have worked together to build a strong company as Wei-Li has steadily increased his scope of responsibility. His track record of delivering innovation, commercial wins, and strong financial growth has shaped Omada and demonstrates that Wei-Li is the right leader to take Omada to the next level of impact and scale," said Sean Duffy regarding Wei-Li Shao's upcoming CEO role.
• "I'm honored to lead Omada and continue building on the strong foundation this incredible team has created," said Wei-Li Shao, President of Omada Health. "Fifteen years ago, Sean designed an innovative solution to help Americans bridge the healthcare gap. Together, we've shown the model works, yet I believe our biggest impact is still ahead. Our results serve as a foundation to raise our ambitions. Now is the time to scale, push harder on our mission, and bend the curve of chronic disease."
• "We delivered another strong quarter, setting quarterly records for revenue of $88 million, GAAP gross margin of 73%, non-GAAP gross margin of 74%, net income of $5 million, and adjusted EBITDA of $11 million. Revenue grew 43% year-over-year. This marks Omada Healths most profitable quarter to date, both in absolute terms and on a margin basis, demonstrating continued operating leverage," said Steve Cook, Chief Financial Officer of Omada Health.

Industry Context

StockSavvy.ai notes that Omada Health's strong performance, particularly in revenue growth and margin expansion, aligns with the increasing demand for virtual-first healthcare solutions and chronic condition management platforms. The company's focus on cardiometabolic care and expansion into areas like cholesterol management positions it well within a growing digital health sector that is seeing significant investment and adoption.

Comparison to Industry Standards

• Omada Health's Q2 2026 revenue growth of 43% significantly outpaces the average growth rate for many established healthcare technology companies, which often see growth in the high single digits to low double digits.
• The reported GAAP gross margin of 73% is exceptionally high for a technology-enabled healthcare service provider, suggesting strong pricing power and efficient operations. Many competitors in the digital health space operate with lower gross margins due to higher customer acquisition costs or service delivery expenses.
• The transition to positive net income and Adjusted EBITDA in Q2 2026 is a critical milestone. While many digital health companies are still in a growth-at-all-costs phase, Omada's demonstrated ability to achieve profitability, even at this stage, suggests a more sustainable business model compared to peers focused solely on top-line expansion.
• The increase in total members by 45% year-over-year indicates successful market penetration and customer acquisition, potentially exceeding industry benchmarks for member growth in specialized care platforms.

Management Changes

Related Party Transactions

• Significant balances are reported with related parties across various balance sheet accounts, including accounts receivable, prepaid expenses, accounts payable, accrued expenses, and deferred revenue, as of June 30, 2026, and December 31, 2025.
• Related party amounts are also included in revenue and cost of revenue line items for both the three and six-month periods ended June 30, 2026 and 2025.

Stakeholder Impact

• Shareholders: Positive impact from strong financial performance, improved profitability, raised outlook, and a well-structured leadership transition, which should support continued value creation.
• Employees: Potential for increased job security and growth opportunities due to the company's strong performance and raised outlook. The leadership transition is planned and aims for continuity.
• Customers/Members: Continued access to and potential expansion of Omada Health's virtual care programs, including new offerings like cholesterol management, leading to improved health outcomes.
• Partners (Health Plans, PBMs, Employers): Continued strong partnership with HCSC and potential for new business as Omada Health expands its offerings and market reach.

Next Steps

• Wei-Li Shao will assume the role of CEO on January 1, 2027.
• Sean Duffy will transition to Executive Chairman on January 1, 2027.
• Jeryl Hilleman will become Lead Independent Director on January 1, 2027.
• Omada Health will host an Investor Day on September 10, 2026.
• The company will continue to focus on disciplined execution to broaden capabilities and deepen customer relationships.

Key Dates

Recommendation

The company delivered better-than-expected results and raised its guidance, coupled with a smooth CEO transition. However, the accumulated deficit and negative free cash flow, along with the inherent risks in the healthcare sector, warrant a cautious 'hold' rating until sustained profitability and positive cash flow generation are consistently demonstrated.

Keywords

virtual healthcare, chronic disease management, cardiometabolic care, diabetes management, hypertension management, weight health, digital health, healthcare provider